TREATMENT OF HYPOGONADAL MEN WITH ORAL TESTOSTERONE UNDECANOATE (TU) IMPROVES PSYCHO-SEXUAL, WELL-BEING AND BODY COMPOSITION PARAMETERS

被引：0
|
作者：
Honig, Stanton
Jed, Kaminetsky
Gittelman, Marc
Swerdloff, Ronald
Danoff, Theodore
Dudley, Robert
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD26-10
引用
收藏
页码：E547 / E547
页数：1
相关论文
共 50 条
  • [31] Metabolic Syndrome Parameters in Hypogonadal Men on Long-Term Treatment with Testosterone Undecanoate (TU) Injections Improve Independently from Age: Observational Data from Two Registry Studies
    Yassin, Aksam A.
    Haider, Ahmad
    Doros, Gheorghe
    Traish, Abdulmaged M.
    Saad, Farid
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [32] AN ASSESSMENT OF THE EFFICACY AND SAFETY OF INTRAMUSCULAR INJECTIONS OF 750 MG TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH NO HISTORY OF PRIOR TESTOSTERONE REPLACEMENT THERAPY DURING A 34 WEEK TREATMENT PERIOD
    Morgentaler, Abe
    Wang, Christina
    Harnett, Mark
    JOURNAL OF ANDROLOGY, 2010, : 73 - 73
  • [33] EFFECTS OF LONG-TERM TESTOSTERONE UNDECANOATE INJECTIONS (TU) ON URINARY AND SEXUAL FUNCTION IN HYPOGONADAL MEN: REAL-LIFE DATA FROM A CONTROLLED REGISTRY STUDY
    Haider, Ahmad
    Haider, Karim Sultan
    Doros, Gheorghe
    Traish, Abdulmaged
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1186 - E1186
  • [34] A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function
    McNicholas, TA
    Dean, JD
    Mulder, H
    Carnegie, C
    Jones, NA
    BJU INTERNATIONAL, 2003, 91 (01) : 69 - 74
  • [35] A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function
    Blacklock, ARE
    BJU INTERNATIONAL, 2003, 92 (04) : 490 - 490
  • [36] Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study
    Francomano, D.
    Bruzziches, R.
    Barbaro, G.
    Lenzi, A.
    Aversa, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (04) : 401 - 411
  • [37] Safety of a New SEDDS Formulation of Oral Testosterone Undecanoate (TU) in Hypogonadal Men: Data from Two Phase 3 Trials with Different Dose-Titration Algorithms
    Swerdloff, Ronald S.
    Salameh, Wael A.
    Dobs, Adrian S.
    Faulkner, Sandra M.
    Dudley, Robert E.
    Flippo, Gregory M.
    Kaminetsky, Jed C.
    Amory, John K.
    Danoff, Theodore M.
    Wang, Christina
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [38] Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip
    J Svartberg
    I Agledahl
    Y Figenschau
    T Sildnes
    K Waterloo
    R Jorde
    International Journal of Impotence Research, 2008, 20 : 378 - 387
  • [39] Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip
    Svartberg, J.
    Agledahl, I.
    Figenschau, Y.
    Sildnes, T.
    Waterloo, K.
    Jorde, R.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (04) : 378 - 387
  • [40] Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study
    D. Francomano
    R. Bruzziches
    G. Barbaro
    A. Lenzi
    A. Aversa
    Journal of Endocrinological Investigation, 2014, 37 : 401 - 411
12345